News | Breast Imaging | November 08, 2018

Kubtec Announces Launch of Mozart Supra Specimen Tomosynthesis System

Advanced Imaging Tool for Breast Cancer Surgery

The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.

KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen Tomosynthesis System will be on display at the Radiological Society of North America (RSNA) in Chicago, IL, Nov. 25-29, 2018.

Built on KUBTECs proprietary specimen tomosynthesis technology, The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery. The Mozart Supra System provides surgeons, radiologists and pathologists with the most advanced tools to provide the best quality of care for breast cancer patients.

Tomosynthesis has proven to be more effective than traditional 2-Dimensional imaging at identifying cancer in mammography and is now available for specimen imaging in the operating room and pathology lab.  This 3-D imaging technology enables surgeons to reduce the need for repeat surgeries and assists them in achieving more pleasing cosmetic outcomes for their patients.

John Leach, vice president of marketing at KUBTEC, said, “With the introduction of the Mozart Supra System, breast surgeons and pathologists can now view 3-Dimensional images of specimens of all sizes, from lymph nodes to mastectomies, solid organs and bone.  What’s more, the system uses an advanced Augmented Intelligence to aid the physician with image interpretation and includes voice activation for hands free usage in the OR.”

The MOZART Supra and MOZART Systems from KUBTEC are the onlyintraoperative breast specimen imaging systems to use tomosynthesis. Other features of the MOZART Supra include: auto-magnification, KUBTEC’s patented Image Blender and a high definition optical camera.

More details on the KUBTEC Mozart Supra Specimen Tomosynthesis System can be found at: www.kubtec.com/supra

Related Content

Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
A new report, Magnetic Resonance Imaging Equipment Market Size, Share & Industry Analysis, conducted by Fortune Business Insights, states that the magnetic resonance imaging (MRI) equipment market reached $7.24 billion in 2019 and is projected to reach $11.36 billion by 2027

Image courtesy of Siemens Healthineers

Feature | Magnetic Resonance Imaging (MRI) | September 21, 2020 | By Melinda Taschetta-Millane
A new report,...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.
The COVID-19 pandemic has impacted every facet of personal life, business operations and healthcare, including breast imaging and breast cancer care.

Getty Images

Feature | Breast Imaging | September 18, 2020 | By Susan Harvey, M.D.
The COVID-19 pandemic has impacted every facet o
News | Artificial Intelligence | September 16, 2020
September 16, 2020 — Konica Minolta Healthcare Americas, Inc.